Formononetin in vivo experiments showed that it can inhibit the growth and proliferation of human colon cancer cells and reduce the invasiveness and vascular endothelial growth factor (VEGF) expression level in tumour tissues25. This evidence concerns the gene VEGFA and malignant colon neoplasm.